Vellus-to-Terminal Hair Follicle Reconversion in Male Pattern Balding in a New Humanized Mouse Model of Androgenetic Alopecia and Its Promotion by Minoxidil and PRP

    A. Keren, R. Paus, Amos Gilhar
    From the encyclopedia
    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Platelet-Rich Plasma →

    growth factors taken from your blood and injected into your scalp to stimulate hair

    Studysummary This study suggests that vellus to terminal hair follicle reconversion can occur in male pattern androgenetic alopecia using an in vivo model with minoxidil and platelet-rich plasma treatment.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    This study challenges the claim that fully miniaturized vellus (V) hair follicles (HFs) in androgenetic alopecia (AGA) cannot reconvert to terminal (T) HFs, even with therapy. Using a novel humanized AGA mouse model, biopsies from 10 male AGA patients were transplanted onto SCID/beige mice, which were then treated with either 5% topical minoxidil (MXL) or intradermal platelet-rich plasma (PRP) for 4 months. Quantitative histomorphometry showed a significant decrease in V and intermediate HFs and an increase in T HFs in treated transplants compared to donor scalp skin (p<0.05, p<0.01). This suggests that V-T reconversion is possible in long-standing AGA, promoted by both MXL and PRP, although intermediate HFs may be more responsive to reconversion than fully miniaturized V HFs, highlighting the importance of early intervention in AGA management.
    Discuss this study in the Community →